0001094891-16-000493.txt : 20160523 0001094891-16-000493.hdr.sgml : 20160523 20160523131556 ACCESSION NUMBER: 0001094891-16-000493 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160520 FILED AS OF DATE: 20160523 DATE AS OF CHANGE: 20160523 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CB Pharma Acquisition Corp. CENTRAL INDEX KEY: 0001619551 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 000000000 STATE OF INCORPORATION: E9 FISCAL YEAR END: 1130 BUSINESS ADDRESS: STREET 1: 24 NEW ENGLAND EXECUTIVE PARK STREET 2: SUITE 105 CITY: BURLINGTON STATE: MA ZIP: 01803 BUSINESS PHONE: 781-652-4500 MAIL ADDRESS: STREET 1: 24 NEW ENGLAND EXECUTIVE PARK STREET 2: SUITE 105 CITY: BURLINGTON STATE: MA ZIP: 01803 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fortress Biotech, Inc. CENTRAL INDEX KEY: 0001429260 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36757 FILM NUMBER: 161668475 BUSINESS ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 BUSINESS PHONE: 781-652-4500 MAIL ADDRESS: STREET 1: 3 COLUMBUS CIRCLE STREET 2: 15TH FLOOR CITY: NEW YORK STATE: NY ZIP: 10019 FORMER NAME: FORMER CONFORMED NAME: CORONADO BIOSCIENCES INC DATE OF NAME CHANGE: 20080310 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: ROSENWALD LINDSAY A MD CENTRAL INDEX KEY: 0000941841 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36757 FILM NUMBER: 161668476 MAIL ADDRESS: STREET 1: 375 PARK AVE CITY: NEW YORK STATE: NY ZIP: 10152 FORMER NAME: FORMER CONFORMED NAME: ROSENWALD LINDSAY MD DATE OF NAME CHANGE: 19950316 4 1 edgar.xml PRIMARY DOCUMENT X0306 4 2016-05-20 0001619551 CB Pharma Acquisition Corp. CNLM 0000941841 ROSENWALD LINDSAY A MD C/O CB PHARMA ACQUISITION CORP. 2 GANSEVOORT STREET, 9TH FLOOR NEW YORK NY 10014 1 1 1 0 Co-Chairman and CEO 0001429260 Fortress Biotech, Inc. 3 COLUMBUS CIRCLE, 15TH FLOOR NEW YORK NY 10019 0 0 1 0 Ordinary Shares 2016-05-20 4 S 0 1020000 D 265000 I By Fortress Biotech, Inc. Mr. Rosenwald is the Chairman, President and Chief Executive Officer of Fortress Biotech, Inc. (formerly Coronado Biosciences, Inc.), and as such, controls the voting and disposition of such securities. Mr. Rosenwald disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that Mr. Rosenwald is the beneficial owner of these securities for puposes of Section 16 or for any other purpose. $0.00000095238 per ordinary share. /s/ Lindsay A. Rosenwald 2016-05-23